Ms. Lao Yuan Yuan is Executive Director of China Assets Ltd., since September 20, 2005. She is also a director of CAIML. Ms. Lao Yuan Yuan is presently a vice president of business development of Crimson Pharmaceutical Limited, a subsidiary of First Shanghai Investments Limited. Prior to joining Crimson, Ms. Lao worked in investment banking division at Merrill Lynch & Co. in New York City, where she was part of the Financial Sponsors Group
Lao graduated magna cum laude from Columbia University where she studied Engineering Management Systems.
Management Efficency
The company has return on total asset (ROA) of (4.25) % which means that it has lost $4.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (13.43) % meaning that it generated substantial loss on money invested by shareholders.
China Assets Limited is a VC arm of Citic Securities Co., Ltd. China Assets holdings [0170] is traded on Hong Kong Stock Exchange in Hong Kong. It is located in Central, and employs 1 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory